Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury.

By A. K. Bose, M. Mocanu, R. Carr, C. L. Brand, D. Yellon. Diabetes, 2005

632 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Molecular Biology, Surgery

View Paper: https://www.semanticscholar.org/paper/ea5291f6405826b1ad3c4b1a43ffc1ec810f4088

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. Juan José Marín-Peñalver
2. Cristina Sevillano-Collantes
3. Iciar Martín-Timón
4. F. J. del Cañizo-Gómez
5. Josephine M. Egan
6. Wook Kim

In Molecular Biology

1. Josephine M. Egan
2. Wook Kim

In Surgery

1. Josephine M. Egan
2. Wook Kim

Citations in the corpus

• Update on the treatment of type 2 diabetes mellitus. (2016, background): “GLP1 also protect against myocardial ischemia [173,174] .”
• The Role of Incretins in Glucose Homeostasis and Diabetes Treatment (2008, background): “…models of ischemia/reperfusion, GLP-1 significantly reduces infarction size compared with the saline control group, and this protection is abolished by Ex-9-39, the cAMP inhibitor Rp-cAMP, the PI3K inhibitor LY294002, and the p42/44 MAPK inhibitor U0126 in the in vitro hearts (Bose et al., 2005).”